Improved assessment of mass drug administration and health district management performance to eliminate lymphatic filariasis. by Carmen Maroto-Camino, Pilar Hernandez-Pastor, Naomi Awaca, Lebon Safari, Janet Hemingway, Marilia Massangaie, Donald Whitson, Caroline Jeffery, Joseph J Valadez

“…Lymphatic filariasis (LF) elimination as a public health problem requires the interruption of transmission by administration of preventive mass drug administration (MDA) to the eligible population living in endemic districts. …”
Get full text

Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti. by Marisa A Hast, Alain Javel, Eurica Denis, Kira Barbre, Jonas Rigodon, Keri Robinson, Tara A Brant, Ryan Wiegand, Katherine Gass, Marc Aurèle Telfort, Christine Dubray

“…<h4>Background</h4>Lymphatic filariasis (LF) has been targeted for global elimination as a public health problem since 1997. …”
Get full text

Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa. by Kimberly Y Won, Keri Robinson, Katy L Hamlin, Joseph Tufa, Margaret Seespesara, Ryan E Wiegand, Katherine Gass, Joseph Kubofcik, Thomas B Nutman, Patrick J Lammie, Saipale Fuimaono

“…Current WHO recommendations for lymphatic filariasis (LF) surveillance advise programs to implement activities to monitor for new foci of transmission after stopping mass drug administration (MDA). …”
Get full text

Population pharmacokinetics of ivermectin after mass drug administration in lymphatic filariasis endemic communities of Tanzania by Adam M. Fimbo, Eulambius M. Mlugu, Eliford Ngaimisi Kitabi, Gerald S. Kulwa, Mohammed A. Iwodyah, Rajabu Hussein Mnkugwe, Peter P. Kunambi, Alpha Malishee, Appolinary A. R. Kamuhabwa, Omary M. Minzi, Eleni Aklillu

“…Abstract Ivermectin (IVM) is a drug of choice used with albendazole for mass drug administration (MDA) to halt transmission of lymphatic filariasis. We investigated IVM pharmacokinetic (PK) variability for its dose optimization during MDA. …”
Get full text

Sociodemographic characteristics as predictors of knowledge regarding mode of transmission of Lymphatic Filariasis among population of Nepal by Ramesh Adhikari, Devaraj Acharya, Aakriti Wagle

“…<h4>Introduction</h4> The majority of the districts of Nepal (63 out of 77) were detected as prevalent of Lymphatic Filariasis (LF), with an average prevalence of 13 percent ranging from less than one to 39 percent in Nepal. …”
Get full text

The History of Bancroftian Lymphatic Filariasis in Australasia and Oceania: Is There a Threat of Re-Occurrence in Mainland Australia? by Catherine A. Gordon, Malcolm K. Jones, Donald P. McManus

Subjects: Get full text

Exploring determinants of hydrocele surgery coverage related to Lymphatic Filariasis in Nepal: An implementation research study. by Choden Lama Yonzon, Retna Siwi Padmawati, Raj Kumar Subedi, Sagun Paudel, Ashmita Ghimire, Elsa Herdiana Murhandarwati

“…It is a common manifestation of lymphatic filariasis (LF) affecting nearly 25 million men worldwide. …”
Get full text

Morbidity management and disability prevention for lymphatic filariasis in Sri Lanka: Current status and future prospects. by Nilmini Chandrasena, Ranjan Premaratna, Indeewarie E Gunaratna, Nilanthi R de Silva

“…Sri Lanka was acknowledged to have eliminated lymphatic filariasis (LF) as a public health problem in 2016, largely due to its success in Mass Drug Administration (MDA) to interrupt disease transmission. …”
Get full text

The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia by Alison Krentel, Kaye Wellings

Subjects: Get full text

Lessons from the Pacific programme to eliminate lymphatic filariasis: a case study of 5 countries by Huppatz Clare, Capuano Corinne, Palmer Kevin, Kelly Paul M, Durrheim David N

“…<p>Abstract</p> <p>Background</p> <p>Lymphatic Filariasis (LF) is an important Neglected Tropical Disease, being a major cause of disability worldwide. …”
Get full text

Integrated morbidity mapping of lymphatic filariasis and podoconiosis cases in 20 co-endemic districts of Ethiopia. by Biruk Kebede, Sarah Martindale, Belete Mengistu, Biruck Kebede, Asrat Mengiste, Fikre H/Kiros, Abraham Tamiru, Gail Davey, Louise A Kelly-Hope, Charles D Mackenzie

“…Lymphatic filariasis (LF) and podoconiosis are neglected tropical diseases (NTDs) that pose a significant physical, social and economic burden to endemic communities. …”
Get full text

Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. by Alexander Yaw Debrah, Sabine Mand, Sabine Specht, Yeboah Marfo-Debrekyei, Linda Batsa, Kenneth Pfarr, John Larbi, Bernard Lawson, Mark Taylor, Ohene Adjei, Achim Hoerauf

“…Lymphatic filariasis is a disease of considerable socioeconomic burden in the tropics. …”
Get full text

Investigating immunological interaction between lymphatic filariasis and COVID-19 infection: a preliminary evidence by Abhinav Sinha, Sanghamitra Pati, Prakash Kumar Sahoo

Subjects: “…lymphatic filariasis…”
Get full text

Lymphatic filariasis in Peninsular Malaysia: a cross-sectional survey of the knowledge, attitudes, and practices of residents by Nazeh M Al-Abd, Zurainee Mohamed Nor, Abdulhamid Ahmed, Abdulelah H Al-Adhroey, Marzida Mansor, Mustafa Kassim

Subjects: “…Lymphatic filariasis…”
Get full text

Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration. by Colleen L Lau, Kimberly Y Won, Luke Becker, Ricardo J Soares Magalhaes, Saipale Fuimaono, Wayne Melrose, Patrick J Lammie, Patricia M Graves

“…As part of the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted mass drug administration (MDA) from 2000-2006, and passed transmission assessment surveys in 2011-2012. …”
Get full text

Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges. by Dziedzom K de Souza, Katherine Gass, Joseph Otchere, Ye Min Htet, Odame Asiedu, Benjamin Marfo, Nana-Kwadwo Biritwum, Daniel A Boakye, Collins S Ahorlu

“…BACKGROUND:Lymphatic filariasis (LF) is endemic in Ghana, and the country has implemented the GPELF strategy since 2000 with significant progress made in the control of the disease. …”
Get full text

Elimination of Lymphatic Filariasis: Mass Drug Administration in Endemic Areas of (Bidar District) Karnataka-2008 by T S Ranganath, N Ramakrishna Reddy

Subjects: Get full text

Use of medicinal plants as a remedy against lymphatic filariasis: Current status and future prospect by Fatima A. Fordjour, Priscilla Osei‐Poku, Afua K. A. Genfi, Kwaw G. Ainooson, Kingsley Amponsah, Patrick K. Arthur, G. Richard Stephenson, Alexander Kwarteng

Subjects: Get full text

Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. by Irvine, M, Stolk, W, Smith, M, Subramanian, S, Singh, B, Weil, G, Michael, E, Hollingsworth, T

“… <h4>Background</h4> <p>Lymphatic filariasis is targeted for elimination as a public health problem by 2020. …”

Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa by Touloupou, P, Retkute, R, Hollingsworth, TD, Spencer, SEF

“…The methodology has been applied to lymphatic filariasis in East Africa to provide estimates of the impact of different intervention strategies against the disease.…”